Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Infant Bacterial Therapeutics AB

Closing information (x1000 EUR)

Closing information 2022/12 2021/12 2020/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 26 More Arrow 40 Less Arrow 30
Earnings before taxes -5,881 More Arrow -4,399 Less Arrow -7,174
EBITDA -5,914 More Arrow -4,359 Less Arrow -7,165
Total assets 31,417 More Arrow 39,942 More Arrow 44,864
Current assets 30,466 More Arrow 38,828 More Arrow 43,648
Current liabilities 1,610 Less Arrow 1,293 Less Arrow 1,013
Equity capital 29,807 More Arrow 38,648 More Arrow 43,851
- share capital 275 More Arrow 299 More Arrow 305
Employees (average) 7 More Arrow 8 More Arrow 10

Financial ratios

Fiscal year 2022/12 2021/12 2020/12
Solvency 94.9% More Arrow 96.8% More Arrow 97.7%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -18.6% More Arrow -10.9% Less Arrow -15.9%
Current ratio 1892.3% More Arrow 3002.9% More Arrow 4308.8%
Return on equity (ROE) -19.7% More Arrow -11.4% Less Arrow -16.4%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees -1 Less Arrow -2 More Arrow 0
Chg. No. of employees % -13% Less Arrow -20% More Arrow 0%

Total value of public sale

Fiscal year 2022/12 2021/12 2020/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.